Farmakovijilans Önemi: Kozmetovijilans
Öz
Anahtar Kelimeler
Kozmetovijilans , advers ilaç reaksiyonu , halk sağlığı , ürün güvenliği
Kaynakça
- 1. Khan Z, Karataş Y, Rahman H. Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education. Ther Adv Drug Saf. 2020;11:2042098620922483.
- 2. Toklu HZ, Antigua A, Lewis V, Reynolds M, Jones J. Cosmetovigilance: A review of the current literature. J Fam Med Prim Care. 2019;8:1540–5.
- 3. Lucca JM, Joseph R, Hussain Al Kubaish Z, Mohammad Al-Maskeen S, Ali Alokaili Z. An observational study on adverse reactions of cosmetics: The need of practice the Cosmetovigilance system. Saudi Pharm J. 2020;28:746–53.
- 4. Jose J, Rubaie MHA, Ramimy HA, Varughese SS. Pharmacovigilance. Sultan Qaboos Univ Med J. 2021;21:e161–3.
- 5. Vigan M, Castelain F. Cosmetovigilance: definition, regulation and use “in practice”. Eur J Dermatol. 2014;24:643–9.
- 6. Altiokka İ, Üner M. Safety in cosmetics and cosmetovigilance, current regulations in Türkiye. Turk J Pharm Sci. 2022;19:610–7.
- 7. Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK). Kozmetik ürün güvenlilik değerlendiricisine, eğitimine ve belgelendirilmesine ilişkin kılavuz [Internet]. 2024 Mar 22 [cited 2025 Jul 31]. Available from: https://www.titck.gov.tr/mevzuat/kozmetik-urun-guvenlilik-degerlendiricisine-egitimine-ve-belgelendirilmesine-iliskin-kilavuz-22032024105525
- 8. Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK). 5324 sayılı Kozmetik Kanunu ve Kozmetik Yönetmeliği [Internet]. Ankara: TİTCK; 2024 [cited 2025 Jul 31]. Available from: https://www.titck.gov.tr/mevzuat
- 9. Berne B, Tammela M, Färm G, Inerot A, Lindberg M. Can the reporting of adverse skin reactions to cosmetics be improved? A prospective clinical study using a structured protocol. Contact Dermatitis. 2008;58:223–7.
- 10. Bilal AI, et al. Cosmetics use-related adverse events and determinants among Jigjiga town residents, Eastern Ethiopia. Dermatol Ther. 2017;7:143–53.
